Autoimmune hepatitis

Clinics in Liver Disease

Volumn 9, Issue 4, 2005, Pages 635-646

  Thiele, Dwain L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; ATORVASTATIN; AUTOANTIBODY; AZATHIOPRINE; BUDESONIDE; CALCIUM; CORTICOSTEROID; CYCLOSPORIN; HYDRALAZINE; MEMBRANE ANTIGEN; MERCAPTOPURINE; METHYLDOPA; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROFURANTOIN; PREDNISOLONE; PREDNISONE; SMOOTH MUSCLE ANTIBODY; T LYMPHOCYTE RECEPTOR; THIOPURINE METHYLTRANSFERASE; URSODEOXYCHOLIC ACID; VITAMIN D;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE HEPATITIS; ARTHRALGIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BONE DENSITY; CATARACT; CHRONIC HEPATITIS; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENZYME BLOOD LEVEL; FATIGUE; GENE MUTATION; GENETIC POLYMORPHISM; GLAUCOMA; HEPATITIS; HEPATITIS C; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LETHARGY; LEUKOPENIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MALAISE; MORTALITY; NONHUMAN; PATHOGENESIS; REVIEW; SCORING SYSTEM; SURVIVAL; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPENIA; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION;

AUTOANTIBODIES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE;

EID: 26044449853     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2005.07.004     Document Type: Review

References (46)

1. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 5 1999 929 938
2. A.J. Czaja, D.K. Freese American Association for the Study of Liver Disease Diagnosis and treatment of autoimmune hepatitis Hepatology 36 2 2002 479 497
3. I.G. McFarlane Definition and classification of autoimmune hepatitis Semin Liver Dis 22 4 2002 317 324
4. G.C. Cook, R. Mulligan, and S. Sherlock Controlled prospective trial of corticosteroid therapy in active chronic hepatitis Q J Med 40 158 1971 159 185
5. I.M. Murray-Lyon, R.B. Stern, and R. Williams Controlled trial of prednisone and azathioprine in active chronic hepatitis Lancet 1 7806 1973 735 737
6. E.C. Wright, L.B. Seeff, and P.D. Berk Treatment of chronic active hepatitis. An analysis of three controlled trials Gastroenterology 73 6 1977 1422 1430
7. R.D. Soloway, W.H. Summerskill, and A.H. Baggenstoss Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis Gastroenterology 63 5 1972 820 833
8. C.P. Strassburg, and M.P. Manns Autoantibodies and autoantigens in autoimmune hepatitis Semin Liver Dis 22 4 2002 339 352
9. P.T. Donaldson Genetics in autoimmune hepatitis Semin Liver Dis 22 4 2002 353 364
10. H.F. Lohr, S. Pingel, and S. Weyer Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis Scand J Immunol 57 4 2003 384 390
11. S.M. Skoog, R.E. Rivard, and K.P. Batts Autoimmune hepatitis preceded by acute hepatitis A infection Am J Gastroenterol 97 6 2002 1568 1569
12. V. Nobili, D. Comparcola, and M.R. Sartorelli Autoimmune hepatitis type 1 after Epstein-Barr virus infection [erratum appears in Pediatr Infect Dis J 2003;22(7):588] Pediatr Infect Dis J 22 4 2003 397
13. S. Seki, T. Kitada, and S. Iwai Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis Hepatogastroenterology 50 53 2003 1274 1277
14. I.G. McFarlane The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis Gut 42 5 1998 599 602
15. K. Agarwal, A.J. Czaja, and D.E. Jones Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis Hepatology 31 1 2000 49 53
16. A. Vogel, C.P. Strassburg, and M.P. Manns 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link Genes Immun 4 1 2003 79 81
17. K.M. Boberg Prevalence and epidemiology of autoimmune hepatitis Clin Liver Dis 6 3 2002 347 359
18. R. Ferrari, G. Pappas, and D. Agostinelli Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type QJM 97 7 2004 407 412
19. G. Toda, M. Zeniya, and F. Watanabe Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis J Hepatol 26 6 1997 1207 1212
20. A. Duchini, J.G. McHutchison, and P.J. Pockros LKM-positive autoimmune hepatitis in the western United States: a case series Am J Gastroenterol 95 11 2000 3238 3241
21. L.O. Poulsen, A.M. Thulstrup, and L. Mellemkjaer Mortality and causes of death in patients with lupoid hepatitis. A long-term follow-up study in Denmark Dan Med Bull 49 3 2002 263 265
22. R.L. Ebbeson, and R.A. Schreiber Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful? Clin Gastroenterol Hepatol 2 10 2004 935 940
23. A. Czaja, and H.A. Carpenter Validation of scoring system for diagnosis of autoimmune hepatitis Dig Dis Sci 41 2 1996 305 314
24. K.M. Boberg, O. Fausa, and T. Haaland Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis Hepatology 23 6 1996 1369 1376
25. L.A. Adams, K.D. Lindor, and P. Angulo The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease Am J Gastroenterol 99 7 2004 1316 1320
26. B.D. Clifford, D. Donahue, and L. Smith High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C Hepatology 21 3 1995 613 619
27. D.L. Thiele, L. DuCharme, and M.R. Cunningham Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients Am J Gastroenterol 91 2 1996 300 308
28. A.J. Czaja, and H.A. Carpenter Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis Liver Int 23 2 2003 116 123
29. B. van Hoek The spectrum of liver disease in systemic lupus erythematosus Neth J Med 48 6 1996 244 253
30. Z.X. Liu, and N. Kaplowitz Immune-mediated drug-induced liver disease Clin Liver Dis 6 3 2002 467 486
31. I.W. Graziadei, G.E. Obermoser, and N.T. Sepp Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis Lupus 12 5 2003 409 412
32. M. Abe, S. Furukawa, and S. Takayama Drug-induced hepatitis with autoimmune features during minocycline therapy Intern Med 42 1 2003 48 52
33. W.H. Summerskill, M.G. Korman, and H.V. Ammon Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared Gut 16 11 1975 876 883
34. P.J. Johnson, I.G. McFarlane, and R. Williams Azathioprine for long-term maintenance of remission in autoimmune hepatitis N Engl J Med 333 15 1995 958 963
35. E. Buchel, W. Van Steenbergen, and F. Nevens Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery Am J Gastroenterol 97 12 2002 3160 3165
36. B. Malhotra, N. Malhotra, and D. Deka Immunosuppressive effect of pregnancy on autoimmune hepatitis: a case report and review of literature Eur J Obstet Gynecol Reprod Biol 101 1 2002 91 92
37. P. Muratori, S. Loffreda, and L. Muratori Spontaneous remission of autoimmune hepatitis during pregnancy Dig Liver Dis 34 8 2002 608 609
38. D. Samuel, S. Riordan, and S. Strasser Severe autoimmune hepatitis first presenting in the early postpartum period Clin Gastroenterol Hepatol 2 7 2004 622 624
39. M.A. Heneghan, S.M. Norris, and J.G. O'Grady Management and outcome of pregnancy in autoimmune hepatitis Gut 48 1 2001 97 102
40. P.G. Langley, J. Underhill, and J.M. Tredger Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis J Hepatol 37 4 2002 441 447
41. A.J. Czaja, H.A. Carpenter, and K.D. Lindor Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial Hepatology 30 6 1999 1381 1386
42. A.J. Czaja, and K.D. Lindor Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis Gastroenterology 119 5 2000 1312 1316
43. S.M. Devlin, M.G. Swain, and S.J. Urbanski Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy Can J Gastroenterol 18 5 2004 321 326
44. A.J. Czaja Treatment of autoimmune hepatitis Semin Liver Dis 22 4 2002 365 378
45. J. Neuberger Transplantation for autoimmune hepatitis Semin Liver Dis 22 4 2002 379 386
46. J.C. Duclos-Vallee, M. Sebagh, and K. Rifai A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence Gut 52 6 2003 893 897